*Rub= related to
inflammation high pitched sweaky yet muffled like sandpaper from turbulent flow aka bruit
*
6
* Disease process that occurs over time * Starts in infancy * Risk factors: age gender diet sedentary life
smoking
* * * * *
SYMPTOMS OF INFERIOR MI: - hypotension from a decrease in preload available to the LV due to d RV emptying
*
8
*
* *
left anterior descending artery(LAD) = supplies anterior and bottom of Left vent and front of the septum * most involved with occlusions * Blockage here results in anterior MI which has higher mortality rate AND more serious dysrhythmias !!!!! * may include 2nd & 3rd degree blocks * diminished ejection fraction & symptoms of heart failure !!!!! * When > 40% of left vent. Is damaged * mortality is extremely high
10
11
*
* 1. Stable Angina: * - no or minimal myocardial injury * - collateral circulation develops * - pain begins with exertion or stress * - pain relieved with rest * - pain lasts less than 20 minutes * - relieved by NTG (may take SL up to * 3 times every 5 minutes) If not relieved * after these 3 doses, pt may be infarcting * -ST segment depression with pain then * returns to normal with pain subsides
12
* 2. Unstable Angina: * - pain resolves with NTG * - similar to stable angina BUT angina * occurs more freq with less exertion * - often begins at rest with increasing * severity * - normal cardiac enzymes * - ST depression with prolonged CP
13
* 3. variant (Prinzmetal) angina: * - rare & associated with angina at rest * - tend to be younger women (smokers) * & pain occurs in early am & with menstrual * - ST elevation (reversible) but cardiac enzymes
norm * - CAUSE: coronary artery spasm occurs * at stenosed area * Treat: responds to NTG * long-term: calcium channel blockers
14
* A. reflux or peptic ulcer disease * B. chest wall pain (pain reproduced on palpation and
localized) * - occurs from bruised/ fx ribs * C. esophageal problems * - achalasia, esophageal spasm * D. pericarditis (will be sed rate, low-grade * fever, viral cause (coxsackievirus) * E. pneumonia * F. Aortic dissection (CV EMERGENCY) watch * for severe pain radiating to back
*
15
* HOW?
* Angina without MI} often relieved with rest and NTG * Angina with MI } may be relieved with rest, NTG, 02, MS,
rescue angioplasty, etc. * Think MONA
http://www.doctorsecrets.com/yourmedicine/heart-attack-cause-symptomstreatment.html
18
*
* - actual necrosis of myocardial tissue * - most cases, atherosclerotic heart disease
present
*-
19
20
*
* Common patterns: * Ant/lat * inf/post * ant/septal * 25% of MI are silent : presents without * chest pain (esp in diabetics with neuropathy) * Patient presents with heart failure, shock,
confusion, delirium (esp in elderly)
21
*
22
*
23
24
*
25
* Symptoms * * ECG within 10 minutes * * ST elevated * * ASA, Troponin, CPK-MB, Morphine, Heparin * * Thrombolytic with 30 minutes if PCI not avail * * PCI in24 hours if avail, within 90 min. * * stent angioplasty *
26
*
* Procedure done at the time of cardiac cath. * Balloon angioplasty is accomplished to widen or
open specific coronary vessel-stent is inserted to maintain patency of the vessel.
27
28
*
* No ST elevation * * Draw Troponin I * * If elevated * * Cardiac cath vs * *
*
* Continuous cardiac monitoring * Oxygen * IV line * Hemodynamic monitoring (discuss in a bit) * Bed rest * Emotional support * Need passive & active ROM to reduce risk of * thromboembolism (immobility)
30
*
* For low cardiac output: * - dobutamine +inotropic * -milrinone +inotropic * For hypotension: * - dopamine ( or at low doses used to * improve renal perfusion) * May need Intraaortic balloon pump
31
*http://people.brunel
.ac.uk/~emstawk/IAB P.htm
32
*
33
* Begins as soon as MI stop * Scar tissue dev. at necrotic area (takes 6-8 wks * May see stages of grief in pt with MI * - - we need to identify depression as mortality at 1
to 5 years with associated depression !!!!
*
34
*
* Papillary muscle rupture * Ventricular aneurysm * Ventricular rupture
35
* Precautions with Nitrates and Viagra use: * - reports of sudden death, dramatic * drop in blood pressure, and further * compromising restricted coronary * arterial perfusion
*
36
*
* Vasodilators to reduce preload/afterload * - nitroglycern or nitroprusside * ACE inhibitors: * - reduce afterload * Beta blockers: * - reduce myocardial oxygen consumption * - decrease heart rate and BP * Statins: * - restrict development of artherosclerosis * & also have anti-inflammatory effects * Platelet inhibitors: * - ASA
37
Platelet activation = treat with GP IIb/IIIa inhibitors examples: Abciximab (ReoPro): 0.25mg/kg IV bolus followed by 0.125ug/kg/min for 12 hours (others: Integrilin, Aggrastat)
40
* Alteplase (tPA, Activase): used most often * Reteplase (rPA, Retavase) a synthetic, 2nd generation
that works more quickly & lower bleeding
*
41
*
* Minimal arterial or venous sticks * Use finger oximetry * Avoid automated blood pressure cuffs (bruising * Assess for signs of bleeding(hypotension, tachycardia,
reduced level of consciousness) * Reperfusion arrhythmias common * - bradycardia and V-tach most common * IF BLEEDING COMPLICATIONS: * -stop fibrinolytic agent, FFP &/or cryoprecipitate to replenish fibrin & clotting factors, Aminocaproic acid (Amicar)
42
*
* Hx of intracranial hemorrhage * Known structural cerebrovascular lesion * Known intracranial tumor * Ischemic stroke <3 months * Severe uncontrolled hypertension * Acute pancreatis * Aortic dissection * Hx of hemorrhagic stroke * pregnancy
43
*
44
Biomarkers: * Troponin I will show elevation IN 3-48hrs of MI period and normalizes after 1-2 weeks <0..06 is negative 0.10-0.60 is intermediate and may indicate injury >0.60 is positive evidence of MI Myoglobin normal is 17-106ng/mL * CPK-MB will show increase 2-12 hrs after MI and normalizes 12-18hr after infarct BNP can be elevated 48 hrs after MI which indicates heart failure
*
45
*
* CBC: anemia * CMP: screening K+, etc * PT, INR * PTT * Lipid profile: looks at total cholesterol (good and
bad)
46
47
*
* ABG: assess acid/base levels * Pulse Oximetry: generally >92% * Holter monitoring: 24+ hr of EKG + events * Stress test: treadmill or pharmacological * Cardiac Catheterization: invasive, NPO 6-8h, consent.
Visualizes chambers, valves, arteries, pressures, CO * Heart-CT scan: assesses CAD * Nuclear scans: assess heart muscle viability * EPS: NPO, consent, IV, assess electrical activity
48
* Low fat low cholesterol diet * Prescribed exercise program 5-7 days a week * Knows correct use of NTG for angina * Management of DM, HTN * Stop smoking * Medications to reduce work load or dilate
50
* 5-7 X week is goal to include stretches with * Strengthens heart muscle, reduces BP, BS,
weight, stress, tension, appetite, LDLs. improves immune system
warm-up, progressive walking program, light weights, stretches with cool down.
51
* Decreased cardiac output r/t Dysrhythmias * Pain r/t lack of 02 to myocardium * Anxiety r/t to feeling of doom, lack of
understanding of medical diagnosis
*
52
* You are asked to evaluate a 55-year old Caucasian woman who presents to the
Emergency Department with the chief complaint of chest pain for several hours. * She awoke with the discomfort at 4:00AM today, and it has been a "ten out of ten" since then. The pain is substernal, radiates to her back, and is associated with moderate-to-severe shortness of breath and nausea. * No previous such episodes are reported, but the patient states there is a strong family history of cardiac disease, and that she has smoked one-half pack of cigarettes daily for the past thirty-five years. * Other than that, she denies past medical or surgical conditions, takes only hormone replacement therapy, and has no known drug allergies. * Social history reveals that the patient is married, has three children, and works as an accountant. * On physical exam, the patient appears to be in mild discomfort due to chest pain, but otherwise appears normal. * Temperature is 97.7F, pulse is 110, blood pressure is 150/100, and respirations are 20. * Head and neck, lung, heart, and abdominal exams are normal. * An EKG is performed, which shows nonspecific T-wave changes in the lateral leads. * Other tests, including troponin-I, cardiac enzymes, and chest x-ray have been performed, but results are still pending.
* What are risk factors? * What are you concerned with? * What to do?
54
confirmation with cardiac catheterization. * Re-route blood vessels using mammary or saphenous v from aorta around block in coronary artery.
* Valve replacement or repair * Septal repair and other congenital repairs * CCU post op, chest tubes * Pre-op teaching with post op expectations
55
*
* 1. damage to blood (platelets, RBCs WBCs &
plasma proteins)
56
* 1. fluid status (fluid leaks from vessels) * 2. O2 sats (indicates excess capillary leaking) * 3. postop bleeding from anticoagulation for
procedure * 4. hemodynamic monitoring * 5. pain relief * 6. dysrhythmia control * 7. warming pt may need vasopressors to maintain BP initially (undesirable to let pt shiver as oxygen demands) (use warmed blankets, warmed blood to infuse, warmed inspired gases)
*
57
*
* 8. bleeding not to exceed 300 mL/hour in first
couple hours then 150-200 ml/hour but average blood loss is 1 L. * Notify physician if excessive. * Autotransfusion of medialstinal blood is filtered & infused * 9. aggressive suctioning then enc coughing * 10. monitor electrolytes to prevent dysrhthmias
58
* 11. dysrhythmias treated pharmacologically * 12. pacing wires placed on right atrium and
ventricle before surgical closure.
59
60
*
61
* CAD, advancing age * HTN is a major factor > CHF x 3 * DM, Smoking, Obesity * Valvular incompetency, alcohol or other
chemicals, idiopathic,(unknown)
*
62
63
64
* This causes stimulation Beta 1=>>HR * Stimulation Beta 2= bronchodilation * Activate Alpha receptors
peripherally=constriction=>>bp
*
66
*
67
* The heart enlarges which results in strain * The increase in volume causes the ventricles
to dilate
*
68
*
* H&P * Chest x-ray: see size of heart and fluid in lungs * EKG: strain, MI * Echocardiogram: size of heart and CO * CBC: anemia * CMP: screening * Thyroid function * ABGs * BNP=B type natriuretic peptide= hormone released in
response to Ventricular stretch ( CHF peptide) * Nuclear studies to determine heart function, EF, tissue viability * Cardiac Cath to determine exact nature of heart function
69
* Decreasing venous return (Preload) * Decreasing BP (Afterload) * Improving gas exchange and 02 * Increasing the CO and reducing anxiety
70
71
*
* I & O q shift * Daily am weights before breakfast and after voiding.
2-3# weight gain in 1-4 days call MD * Sodium restricted diet * Medications: to decrease intravascular volume thus reducing venous return, dilate and reduce BP and improve contractility * surgery * http://chfsolutions.com/zip_how_aquapheresis_work s.html#
72
therapy
No electrolyte disturbances Ultrafiltration decreases ECF volume more than a comparable volume of diuretic-induced fluid loss
*
* ACE inhibitors ( proven to mortality in CHF * Beta blockers (proved to mortality) * - begin once pt diuresis occurs) * Diuretics (loop and K+ sparing) * Spironolactone (proven to mortality in class IV
CHF) * Digoxin may be used (doesnt improve mortality in CHF BUT improves symptoms, hosptialization
74
75
* Food decreases absorption * Give on an empty stomach * Postural hypotension (monitor) * Watch for hyperkalemia, angioedema,
PERSISTENT DRY COUGH
*
* Prototype: LOSARTAN * Similar actions to ACE inhibitor * These meds are a substitute for pts who cannot tolerate
ACE inhibitors (those with severe cough or angioedema) * - lowers BP * - reduces morbidity & mortality assoc. with * hypertension * Only need once a day dosing * Adverse effects similar to ACE inhibitors but without the cough * Contraindicated with pregnancy
77
78
*
* ABSOLUTE improved systolic functioning &
reverses cardiac remodeling
* Initially may have exacerbation of symptoms * Decreases heart rate & inhibits release of renin * Two drugs approved for heart failure: * 1. Carvedilol (nonselective B-adrenoreceptor
antagonist that also blocks adrenoreceptors
79
80
*
* By dilating venous blood vessels, leads to decrease in
cardiac preload
* NITRATES
81
Diuretics
The use of loop diuretics in ADHF patients with dyspnea and shortness of breath is standard therapy
In patients with ADHF, diuretics
* Decrease plasma vol. * * which will decrease venous return (preload) * * which decreases cardiac workload & Oxygen
demand
*
84
*
85
*
86
* Hypokalemia leads to serious arrhythmias * - will see this most in pts on thiazide or loop
diuretics (prevented by using a potassium-sparing diuretic OR supplement with potassium chloride )
*
87
* Explanation of heart failure * Expected S/S and when to call MD * Self monitoring of daily weights * Know medications and need to take them * 2000mg sodium restricted diet * Importance of low level daily exercise program
(energy conservation) * Prognosis / advanced directives
*
88
*
89
* Interventions: PREVENTION is key, PCN like * Educate pt and family about prophylactic
Antibx treatment
90
*
*Inflammation of pericardial sac *3 causes: *Infectious *Coxsackie Virus B *Respiratory diseases *Noninfectious *Uremia *AMI *Surgery *Autoimmune *Rhuematoid *Drug Reactions *Connective Tissue Disorders
91
92
* Uncommon * Frequently associated with pericarditis * Usually viral in nature * S/S: fatigue, malaise, achy joints, GI upset, flu like
symptoms
*
94
* Fever- (99-105) * Chills and night sweats may accompany * Malaise, fatigue and weight loss * Appearance of petechiae in the mouth, conjunctiva
and legs
*
95
96
97
98
* (Also referred to as regurgitation) * The inability of the valves to close completely. * Allows the blood to backflow. * i.e., After the L A has contracted some of the
blood will flow back into the L A
*
99
rheumatic fever. * Valve leaflet become rigid and shorten, prevents closure of valve. * Hypertrophy of Left Atrium and Ventricle = L sided heart failure occurs * Murmur heard. F/U with echocardiogram * Edema and shock appear quickly * Afib is common
*
100
*
* Mitral valve leaflets become thickened and
fibrotic. * Rheumatic heart disease is a common cause * Affect women age 20-40 * S/S: dyspnea, afib, dry cough, palpitations, angina, crackles, fatigue, CHF may develop * TX if failure develops: Digoxin, Lasix, beta blockers, and anti arrhythmics, lo Na diet, etc * Will monitor with yearly echocardiogram * Surgery if worsens * Prophylactic antibiotics prior to invasive procedure or dental work
101
Cardiac insufficiency can be caused by many factors by a swelling of the heart muscle (1), an enlargement of the hollow chambers in the heart (2), a heart attack (3) or a blood clot (4).
102
* Occurs when valve cusps become fibrotic and calcify. * Most commonly caused by aging and atherosclerosis. * Occurs most predominantly in men * Untreated will lead to Left sided CHF * S/S: dyspnea is most common, syncope, angina
*
103
*
* Caused primarily by rheumatic fever * May also be caused by chronic HTN * Predominantly in men * Hypertrophy of the Left ventricle and
eventually to left sided CHF
104
* Presents with increased ventricular pressures * 3 common presentations of: * 1. dilated (most common) * 2. hypertrophic * 3. constrictive * Prognosis is POOR * NO CURATIVE MEASURES AT THIS TIME
*Cardiomyopathies: heart
muscle disease
105
106
*
* Dilated cardiomyopathy: dilation of cardiac chambers * redux of ventricular contractile funx * Diagnosed: echocardiogram * TREATMENT: * similar to CHF * - inotropic agents * -diuretics * - vasodilators (ACE inhibitors) * -beta blockers * To prevent sudden cardiac death; implant cardioverterdefibrillator * Need intra-aortic balloon to stabilize pt * NEED HEART TRANSPLANT
107
* Inability of heart to relax during diastole * Goal: reduce afterload (beta-blockers, diuretics) * Causes: idiopathic, systemic hypertension, genetic * -atrial & vent arrhythmias seen in of these pts are
responsible for sudden death * S/S: * - dyspnea, angina, arrhythmias cardiac failure, * very forceful apical impulse * sudden death (most common in ages 10 to 35 and occurs during strenuous exertion)
108
* - very noncompliant ventricular muscle * -diminished LV cavity dimensions * - ventricular volumes decreased * CAUSES: * - idiopathic * - interstitial disease * - radiation * - drug toxicity
*
109
*
110
* Purposes:
* Aid in diagnosis * Assist in guiding therapies * Evaluating response to therapies
111
*
* Obtain IV NS 0.9% and transducer system * Attach the transducer to the IV flush solution and
prime the tubing, removing air bubbles
dead end caps
* Replace all vented caps with non vented sterile * Inflate pressure bag to 300mmHg * Assist the patient into supine position with HOB <or
= to 45 degrees
* Measure and mark phlebostatic axis with marker * Level air fluid interface with that axis * Zero the system * Set alarm limits
112
* Heparin influences the patency of the art lines * Care should be taken so heparin induced
thrombocytopenia is not initiated
* Occurs 4-7 days after heparin exposure * Client at risk for immune response * Thrombosis risk increases
*
113
reference each
114
115
* Do Qshift and with each turn * Zeroing calibrates the system to atmospheric
pressure.
* Procedure: * Turn stopcock closest to pt to off position * Remove cap * Hit zeroing on monitor * Wait for display to say zero * Turn stopcock to neutral position
116
* Uses built in flush system (pigtail) * Quickly pull and release * Perform Q8-12 hours, after blood sampling, or
if accuracy is questioned
*
117
118
* Right atrium * Uses: sepsis, * Obtain consent * Trendelenburg or Supine position for placement * DO NOT USE FOR IV infusion or monitoring until
xray placement confirmation
* Reflects BP in vena cava and rt atrium * 2-6 mmHg is adequate range * Assess site at least Qshift.
119
*
* Multiple lumen * Can measure temp in pulmonary artery * Balloon is inflated up to 1.5ml air * Over inflation can rupture artery and balloon * Hemoptysis is presenting sign * Place pt with affected side down to prevent leaking into
unaffected side and call doctor immediately.
* Assess patient (electrolytes, coag., acid base) * Set up per facility policy or like example earlier * Complications: infection, air emboli, pneumothorax, artery
rupture, pulmonary infarction, arrythmias
120
122
* http://www.accd.edu/SAC/NURSING/math/de
fault.html
* A. * B. * C. * D.
93.75 cc/hr
*
123
* 2) Convert lbs to kg. 110 / 2.2 = 50 * 3) Use formula for rate: Dose (5) x kg (50) x 60
/ concentration (1600)
*
124
* 2. Nitroglycerin is infusing at 16 ml/hr. The * A. 5.33 mcg/min * B. 53.3 mcg /min * C. 32 mcg/min * D. 18 mcg/min
bag has 50 mg NTG in 250 ml D5W. How many mcg/min is the client receiving?
125
*
126
127
* 1.2
*
128
*Right patient *Right medication *Right dose *Right route *Right time
129
1.
2.
3.
Read the label of the medication as it is removed from the shelf, unit dose cart, refrigerator, or dispensing system Read the label of the medication when comparing it with the MAR Read the medication label again before administering the medication to the patient
130
Infiltration
*
* 1. end-stage, ischemic, valvular, or congenital
heart disease with maximum med therapy, not amendable to surgery * 2. Class III IV heart failure with max med therapy * 3. prognosis for 1 year survival <75% * 4. age <65 years * 5. psychologically stable, compliant * 6. strong family support system
133
*
* 7. able to adhere to complex med regimen * 8. absence of the following * - systemic disease or infection * - serious, irreversible impariment of hepatic,
renal, pulmonary functions * - recent CVA or neurologic defects * - peptic ulcer disease * - active substance abuse * - pulmonary vascular resistance >6 wood units * - psychological instability * - malignancy * 9. relative contraindications: * - diabetes and advanced periph atherosclerosis
134